Top

Gepubliceerd in:

2011 | OriginalPaper | Hoofdstuk

5. Genderspecifieke Aspecten van Hartritmestoornissen

Auteurs : Drs. Lieve van Casteren, Dr. Arif Elvan, Drs. Amber Otten, Drs. Bernadette van Casteren

Gepubliceerd in: Handboek gynaecardiologie

Uitgeverij: Bohn Stafleu van Loghum

Abstract

Wereldwijd is er een toenemende aandacht voor hartritmestoornissen, enerzijds omdat de bevolking ouder wordt, anderzijds omdat klachten vaker gemeld worden en er duidelijke verbeteringen zijn in de behandeling daarvan. Door een effectievere behandeling van het acuut coronair syndroom (ACS) is de prevalentie van ventriculaire ritmestoornissen veel lager geworden, maar omdat patiënten uiteindelijk vaak hartfalen krijgen en langer leven komen daar weer andere ritmeproblemen voor terug.

vorige hoofdstuk Genderverschillen bij Hartfalen

volgende hoofdstuk Cardiovasculair Risicomanagement Bij Vrouwen

Liu K, Ballew C, Jr DR, Sidney S, Savage PJ, Dyer A, et al. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. Hypertension 1989; 14: 218–26.PubMedCrossRef

Kadish AH. The effect of gender on cardiac electrophysiology and arrhythmias. In: Zipes DP, Jaliffe J, eds. Cardiac Electrophysiology: From cell to bedside; 2nd ed. Philadelphia (Penn): Saunders, 1995; 1268–75.

Burke JH, Ehlert FA, Kruse JT, Parker MA, Goldberger JJ, Kadish AH. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 1997; 79: 178–81.PubMedCrossRef

Rautaharju PM, Kooperberg C, Larson JC, LaCroix A. Electrocardiographic predictors of incident congestive heart failure and all-cause mortality in postmenopausal women: the Women’s Health Initiative. Circulation 2006; 113: 481–89.PubMedCrossRef

Rautaharja P, Zhou S, Wong S, Calhoun H, Berenson G, Prineas R, Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992; 8: 690–95.

Verkerk AO, Wilders R, Tan HL. Gender disparities in torsade de pointes ventricular tachycardia. Neth Heart J 2007; 15: 405–11.PubMedCrossRef

Burke JH, Goldberger JJ, Ehlert FA, Kruse JT, Parker MA, Kadisch AH. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med. 1996; 100: 537–43.PubMedCrossRef

Rautaharju PM, Surawics B, Gettes LS. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. J Am Coll Cardiol 2009; 53: 981–91.CrossRef

Liuba I, Jönsson A, Safström K, Walfridsson H. Gender-related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol 2006; 97: 1645–49.CrossRef

10.

Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 1993; 72: 838–40.PubMedCrossRef

11.

Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol 2003; 42: 1103–7.PubMedCrossRef

12.

Deneke T, Mügge A, Müller P, Groot J de. Therapeutic implications of gender differences in supraventricular cardiac arrhythmias: lessons of life cannot be learned in a day. Expert Rev Cardiovasc Ther 2009; 7: 879–82.PubMedCrossRef

13.

Liu S, Yuan S, Hertervig E, Kongstad O, Olsson SB. Gender and atrioventriculaire conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome. J Electrocardiol 2001; 34: 295–301.PubMedCrossRef

14.

Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm 2005; 2: 1277-82.PubMedCrossRef

15.

Schulze-Bahr E, Kirchhoff P, Eckardt L, Bertrand J, Breithardt G. Gender differences in cardiac arrhythmias. Herz 2005; 30: 390–400.PubMedCrossRef

16.

Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Study. JAMA 1994; 271: 840–44.PubMedCrossRef

17.

Feinberg WM, Blackshear JL, Laupacis A, Kronmol R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469–73.PubMedCrossRef

18.

Dart AM, Du XJ, Kingwell BA. Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res 2002; 53: 678–87.PubMedCrossRef

19.

Tada H, Sticherling C, Cough SP, Baker RL, Wasmer K, Daoud EG, et al. Gender and age differences in induced atrial fibrillation. Am J Cardiol 2001; 88: 436–38.PubMedCrossRef

20.

Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europa: a report from the euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007; 49: 572–77.PubMedCrossRef

21.

Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk ofdeath: the Framingham Heart Study. Circulation 1998; 98: 946–52.PubMedCrossRef

22.

Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: the Euro Heart Survey on AF. Chest 2010; 137: 263–72.PubMedCrossRef

23.

Alings AMW. Preventie van CVA bij boezemfibrilleren. Hartbulletin 2011; 42: 30–33.

24.

Ten Cate H. Farmacologie van nieuwe orale anticoagulantia. Hartbulletin 2011; 42: 40–43.

25.

Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD, et al. Outcome and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010; 7: 167–72.PubMedCrossRef

26.

Suttorp MJ, Kingma H, Koomen EM, HofA van ‘t, Tijssen JE, Lie KI. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993; 71: 710-13.PubMedCrossRef

27.

Benito B, Sarkozy A, Mont L,Henkens S, Berruezo A, Tamborero D, Arzamendi D, et al. Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol 2008; 52: 1567–73.PubMedCrossRef

28.

www.qtdrugs.org.

29.

Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, et al. Risk stratification in the long-QT syndrome. N Eng J Med 2003; 348: 1866–74.CrossRef

30.

Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, Schwartz PJ, Andrews M, for the LQTS investigators. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. Circulation 1998; 97: 451–56.PubMedCrossRef

31.

Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences in cardiac arrest survivors. Circulation 1996; 93: 1170-76.PubMedCrossRef

32.

Kannel WB, Wilson PWF, D’Agostino RB. Sudden coronary death in women. Am Heart J 1998; 136: 205-12.PubMedCrossRef

33.

Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Heart J 2004; 25: 88–95.PubMedCrossRef

34.

Lamas GA, Pashos CL, Normand SL, McNeil B. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation 1995; 91: 1063–69.PubMedCrossRef

35.

Nowak B, Misselwitz B, Erdogan A, Funck R, Irnich W, Israel CW, Olbrich HG, Schmidt H, Sperzel J, Zegelman M. Do gender differences exist in pacemaker implantation? Results of an obligatory external quality control program. Europace 2010; 12: 210–15.PubMedCrossRef

36.

Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Peiper K, Buxton AE. mustt Investigators. Influence of gender on arrhythmia characteristics and outcome in the Multicenter Unsustained Tachycardia Trial. J Cardiovasc Electrophysiol 2004; 15: 993–98.PubMedCrossRef

37.

Zareba W, Moss AJ, Hall WJ, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H. MADIT II Investigators. Clinical course and implantable cardioverter defibrillator therapy in postinfarct women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2005; 16: 1265–70.PubMedCrossRef

38.

Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee Kl, Johnson GW, Domanski M, Bardy GH. Primary prevention with defibrillator therapy in women: Results from the sudden cardiac death in heart failure trial. J Cardiovasc Electrophysiol 2008; 19: 720–24.PubMedCrossRef

39.

Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, et al. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 2010; 7: 876–82.PubMedCrossRef

40.

Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillator for primary and secondary prevention of sudden cardiac death. JAMA 2007; 298: 1517–24.PubMedCrossRef

41.

Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect ofcardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539–49.PubMedCrossRef

42.

Moss AJ, Hall WJ, Cannon DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Eng J Med 2009; 361: 1329–38.CrossRef

Titel: Genderspecifieke Aspecten van Hartritmestoornissen
Auteurs: Drs. Lieve van Casteren
Dr. Arif Elvan
Drs. Amber Otten
Drs. Bernadette van Casteren
Uitgeverij: Bohn Stafleu van Loghum
Boek: Handboek gynaecardiologie
Print ISBN: 978-90-313-8781-6

Elektronisch ISBN: 978-90-313-8782-3

Copyright: 2011
DOI: https://doi.org/10.1007/978-90-313-8782-3_5

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen